These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 12871312)

  • 21. Role of P2Y1 purinoceptor in ADP-induced platelet activation.
    Savi P; Beauverger P; Labouret C; Delfaud M; Salel V; Kaghad M; Herbert JM
    FEBS Lett; 1998 Feb; 422(3):291-5. PubMed ID: 9498802
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of P2Y receptor subtypes in platelet-derived microparticle generation.
    Kahner BN; Dorsam RT; Kunapuli SP
    Front Biosci; 2008 Jan; 13():433-9. PubMed ID: 17981558
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential involvement of the P2Y1 and P2Y12 receptors in platelet procoagulant activity.
    Leon C; Ravanat C; Freund M; Cazenave JP; Gachet C
    Arterioscler Thromb Vasc Biol; 2003 Oct; 23(10):1941-7. PubMed ID: 12933533
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The ADP antagonist MRS2179 regulates the phenotype of smooth muscle cells to limit intimal hyperplasia.
    Liu R; Ma S; Lu Z; Shen H; Sun L; Wei M
    Cardiovasc Drugs Ther; 2015 Feb; 29(1):23-9. PubMed ID: 25528944
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synergistic action between inhibition of P2Y12/P2Y1 and P2Y12/thrombin in ADP- and thrombin-induced human platelet activation.
    Nylander S; Mattsson C; Ramström S; Lindahl TL
    Br J Pharmacol; 2004 Aug; 142(8):1325-31. PubMed ID: 15265806
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Benzoyl ATP is an antagonist of rat and human P2Y1 receptors and of platelet aggregation.
    Vigne P; Hechler B; Gachet C; Breittmayer JP; Frelin C
    Biochem Biophys Res Commun; 1999 Mar; 256(1):94-7. PubMed ID: 10066429
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MRS2500 [2-iodo-N6-methyl-(N)-methanocarba-2'-deoxyadenosine-3',5'-bisphosphate], a potent, selective, and stable antagonist of the platelet P2Y1 receptor with strong antithrombotic activity in mice.
    Hechler B; Nonne C; Roh EJ; Cattaneo M; Cazenave JP; Lanza F; Jacobson KA; Gachet C
    J Pharmacol Exp Ther; 2006 Feb; 316(2):556-63. PubMed ID: 16236815
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Platelet aggregometry and receptor binding to predict the magnitude of antithrombotic and bleeding time effects of clopidogrel in rabbits.
    Wong PC; Crain EJ; Watson CA; Jiang X; Hua J; Bostwick JS; Ogletree ML; Schumacher WA; Rehfuss R
    J Cardiovasc Pharmacol; 2007 May; 49(5):316-24. PubMed ID: 17513951
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ADP receptors--targets for developing antithrombotic agents.
    Kunapuli SP; Ding Z; Dorsam RT; Kim S; Murugappan S; Quinton TM
    Curr Pharm Des; 2003; 9(28):2303-16. PubMed ID: 14529392
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel P2Y(12) adenosine diphosphate receptor antagonist that inhibits platelet aggregation and thrombus formation in rat and dog models.
    Wang YX; Vincelette J; da Cunha V; Martin-McNulty B; Mallari C; Fitch RM; Alexander S; Islam I; Buckman BO; Yuan S; Post JM; Subramanyam B; Vergona R; Sullivan ME; Dole WP; Morser J; Bryant J
    Thromb Haemost; 2007 May; 97(5):847-55. PubMed ID: 17479197
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decreased platelet aggregation, increased bleeding time and resistance to thromboembolism in P2Y1-deficient mice.
    Fabre JE; Nguyen M; Latour A; Keifer JA; Audoly LP; Coffman TM; Koller BH
    Nat Med; 1999 Oct; 5(10):1199-202. PubMed ID: 10502826
    [TBL] [Abstract][Full Text] [Related]  

  • 32. P2Y12, a new platelet ADP receptor, target of clopidogrel.
    Herbert JM; Savi P
    Semin Vasc Med; 2003 May; 3(2):113-22. PubMed ID: 15199474
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of purinergic P2Y1 receptors in regulation of vasopressin and oxytocin secretion.
    Song Z; Gomes DA; Stevens W
    Am J Physiol Regul Integr Comp Physiol; 2009 Aug; 297(2):R478-84. PubMed ID: 19515986
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contribution of P2Y(1) receptors to ADP signalling in mouse spinal cord cultures.
    Atterbury-Thomas AE; Leon C; Gachet C; Forsythe ID; Evans RJ
    Neurosci Lett; 2008 Apr; 435(3):190-3. PubMed ID: 18343032
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The platelet P2 receptors in thrombosis.
    Gachet C; Hechler B
    Semin Thromb Hemost; 2005 Apr; 31(2):162-7. PubMed ID: 15852219
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Direct excitation of inhibitory interneurons by extracellular ATP mediated by P2Y1 receptors in the hippocampal slice.
    Kawamura M; Gachet C; Inoue K; Kato F
    J Neurosci; 2004 Dec; 24(48):10835-45. PubMed ID: 15574734
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitation of the P2Y(1) receptor with a high affinity radiolabeled antagonist.
    Waldo GL; Corbitt J; Boyer JL; Ravi G; Kim HS; Ji XD; Lacy J; Jacobson KA; Harden TK
    Mol Pharmacol; 2002 Nov; 62(5):1249-57. PubMed ID: 12391289
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of P2 receptor subtypes producing dilation in rat intracerebral arterioles.
    Horiuchi T; Dietrich HH; Hongo K; Dacey RG
    Stroke; 2003 Jun; 34(6):1473-8. PubMed ID: 12730558
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical pharmacology of the adenosine diphosphate (ADP) receptor antagonist, clopidogrel.
    Schrör K
    Vasc Med; 1998; 3(3):247-51. PubMed ID: 9892518
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 2-Chloro-N6-methyl-(N)-methanocarba-2'-deoxyadenosine-3',5'-bisphosphate is a selective high affinity P2Y1 receptor antagonist: commentary on Boyer et al.
    King BF
    Br J Pharmacol; 2002 Apr; 135(8):1839-40. PubMed ID: 11959784
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.